<SEC-DOCUMENT>0001826667-25-000103.txt : 20250724
<SEC-HEADER>0001826667-25-000103.hdr.sgml : 20250724
<ACCEPTANCE-DATETIME>20250724173008
ACCESSION NUMBER:		0001826667-25-000103
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250724
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250724
DATE AS OF CHANGE:		20250724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TriSalus Life Sciences, Inc.
		CENTRAL INDEX KEY:			0001826667
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				853009869
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39813
		FILM NUMBER:		251147995

	BUSINESS ADDRESS:	
		STREET 1:		6272 WEST 91ST AVENUE
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80031
		BUSINESS PHONE:		415 336 8917

	MAIL ADDRESS:	
		STREET 1:		6272 WEST 91ST AVENUE
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80031

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MedTech Acquisition Corp
		DATE OF NAME CHANGE:	20200930
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tlsi-20250724.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e4ff8340-6069-4af7-8725-d16f4b9c41e6,g:811176a3-0737-48fd-9061-9992c5c8ac23,d:8cf7b74a02594e8d997d93e7e111f325-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2025" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>tlsi-20250724</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001826667</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-26">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-27">12/31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="tlsi-20250724.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001826667</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-24</xbrli:startDate><xbrli:endDate>2025-07-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001826667</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-24</xbrli:startDate><xbrli:endDate>2025-07-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001826667</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-24</xbrli:startDate><xbrli:endDate>2025-07-24</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8cf7b74a02594e8d997d93e7e111f325_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:139%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:139%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:139%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">July&#160;24, 2025</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:139%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">TRISALUS LIFE SCIENCES, INC.</ix:nonNumeric></span></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%">(Exact name of registrant as specified in its charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.323%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39813</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">85-3009869</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6272 W 91st Ave</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Westminster</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Colorado</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">80031</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive office)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">(888)</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:139%"> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%"><ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">321-5212</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">(Registrant's telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (Former name or former address, if changed since last report)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.138%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.662%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))</span></div></td></tr></table><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.467%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-17">Common stock, $0.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-18">TLSI</ix:nonNumeric></span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq</ix:nonNumeric> Global Market</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-20">Warrants, each whole warrant exercisable for one share of registrant's common stock at an exercise price of $11.50 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-21">TLSIW</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-22">Nasdaq</ix:nonNumeric> Global Market</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:139%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-23">x</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-24">o</ix:nonNumeric></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.157%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 3.03</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Material Modifications to Rights of Security Holders.</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 3.03.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.157%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.03</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, on June 23, 2025, TriSalus Life Sciences, Inc. (the &#8220;Company&#8221;), announced the commencement of (i) its offer (the &#8220;Offer&#8221;) to the holders of outstanding shares of its Series A Convertible Preferred Stock, $0.001 par value per share (the &#8220;Preferred Stock&#8221;) identified in the Prospectus/Offer to Exchange that forms a part of the Company&#8217;s Registration Statement on Form S-4 (Registration No. 333-288250), filed with the U.S. Securities and Exchange Commission on June 23, 2025, the opportunity to receive that number of shares of common stock of the Company, par value $0.0001 per share (&#8220;Common Stock&#8221;) equal to the quotient of (i) the sum of (a) the Liquidation Preference (as defined in the Certificate of Designations of the Preferred Stock (the &#8220;Certificate of Designations&#8221;)) and (b) the Accrued Dividends (as defined in the Certificate of Designations of the Preferred Stock) if not otherwise paid by the Company, that would have accrued through August&#160;10, 2027 (the &#8220;Exchanged Value), divided by (ii) $4.00, in exchange for each share of Preferred Stock tendered by the holder and exchanged pursuant to the Offer, and (ii) the solicitation of consents (the &#8220;Consent Solicitation&#8221;) from holders of the outstanding shares of Preferred Stock to amend the Certificate of Designations, which governs the Preferred Stock (the &#8220;Preferred Stock Amendment&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Certificate of Designations, certain amendments, including the Preferred Stock Amendment, require the vote or written consent of holders of at least a majority of the then outstanding shares of Preferred Stock (the &#8220;Consent Threshold&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, parties representing approximately 55% of the outstanding shares of Preferred Stock have agreed to tender their shares of Preferred Stock in the Offer and to consent to the Preferred Stock Amendment in the Consent Solicitation pursuant to tender and support agreements (each, a &#8220;Tender and Support Agreement&#8221;). Accordingly, if the other conditions described in the Prospectus/Offer to Exchange are satisfied or waived, then the Preferred Stock Amendment will be adopted with respect to the Preferred Stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The Offer and Consent Solicitation expired at one minute after 11:59 p.m., Eastern Standard Time, on July&#160;23, 2025, (the &#8220;Expiration Date&#8221;). The Company has been advised that 3,551,502 shares of Preferred Stock, which represents approximately 98.82% of the outstanding shares of Preferred Stock, were validly tendered and not validly withdrawn prior to the Expiration Date. The Company expects to accept all validly tendered Preferred Stock for exchange and settlement on or before August 1, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Consent Solicitation, the Company received the requisite approval to satisfy the Consent Threshold. Accordingly, on July 24, 2025, the Company filed the Preferred Stock Amendment with the Secretary of State of the State of Delaware. The Preferred Stock Amendment will permit the Company to require that all shares of Preferred Stock that are outstanding upon the closing of the Offer be converted into the number of shares of Common Stock equal to the quotient of (i) the sum of (a) the Liquidation Preference (as defined in the Certificate of Designations (defined below)) and (b) the Accrued Dividends (as defined in the Certificate of Designations) if not otherwise paid by the Company, that would have accrued through closing the Offer (the &#8220;Exchanged Value&#8221;), divided by the Conversion Price (as defined in the Certificate of Designations, as such term will be amended by the Preferred Stock Amendment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Preferred Stock Amendment is qualified in its entirety by reference to the Preferred Stock Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.157%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.07</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Submission of Matters to a Vote of Security Holders.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Item 5.03 of this Current Report on Form 8-K is incorporated by reference into this Item 5.07.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.157%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 8.01</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Other Events.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 24, 2025, the Company issued a press release announcing the final results of the Offer and Consent Solicitation. A copy of the press release is attached as Exhibit 99.1 and is incorporate by reference herein.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.919%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31certificateofamendment.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of TriSalus Life Sciences, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991closingofpsexchangeof.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Press Release of TriSalus Life Sciences, Inc. dated July&#160;24, 2025</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.722%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.138%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.462%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date: July&#160;24, 2025</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">TriSalus Life Sciences, Inc.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mary Szela</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Mary Szela</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex31certificateofamendment.htm
<DESCRIPTION>EX-3.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="icee4a3f38c2e40ea87c27bd75d0f1076_37"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 3.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF AMENDMENT OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">OF SERIES A CONVERTIBLE PREFERRED STOCK</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">OF TRISALUS LIFE SCIENCES, INC.</font></div><div style="margin-top:3pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuant to Section 242 of the</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Delaware General Corporation Law</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Certificate of Amendment to the Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is dated as of July 24, 2025.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of TriSalus Life Sciences, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Corporation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), pursuant to the authority granted to it by the Second Amended and Restated Certificate of Incorporation of the Corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Certificate of Incorporation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and Section 151 of the Delaware General Corporation Law (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">DGCL</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), has previously fixed the rights, preferences, restrictions and other matters relating to a series of the Corporation&#8217;s preferred stock, consisting of 5,000,000 authorized shares of preferred stock, classified as Series A Convertible Preferred Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and the Certificate of Designations, Preferences and Rights of the Preferred Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Certificate of Designations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) was initially filed with the Secretary of State of the State of Delaware on August 10, 2023 evidencing such terms&#59;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, pursuant to Sections 8(b) and 8(c) of the Certificate of Designations, the Certificate of Designations or any provision thereof may be amended by obtaining the affirmative vote at a meeting duly called for such purpose of the holders of at least a majority of the then-issued and outstanding shares of Preferred Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Required Holders</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), voting separately as a single class, and with such other stockholder approvals, if any, as may then be required pursuant to the DGCL, the Certificate of Incorporation and the Corporation&#8217;s By-Laws&#59;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Required Holders pursuant to the Certificate of Designations and the DGCL have approved this Amendment on the terms set forth herein&#59; and</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Board has duly adopted resolutions proposing to adopt this Amendment and declaring this Amendment to be advisable and in the best interest of the Corporation and its stockholders.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, this Amendment has been duly adopted in accordance with Section 242 of the DGCL and has been executed by a duly authorized officer of the Corporation as of the date first set forth above to amend the terms of the Certificate of Designations as follows&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">1. The following definitions are added in alphabetical order to Section 3 (Definitions) of the Certificate of Designations&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Call Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(d)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Call Notice</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 7(d)(i).</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Call Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">DTC</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means The Depository Trust Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issued Common Call Shares</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">2. The following definitions in Section 3 (Definitions) are hereby amended and restated to read as follows&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Conversion Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, from and after February 10, 2025, with respect to each share of Preferred Stock, $5.277 per share, as adjusted pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Threshold Amount</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means 19.90% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to an applicable Conversion Notice or Call Notice.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">3. The following definition is struck from Section 3 (Definitions)&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Initial Conversion Price</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means with respect to each share of Preferred Stock, $10.00 per share.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">4. Section 4(a)(ii) is hereby amended and restated to read as follows&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(ii) In addition to any dividends pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, the Corporation shall pay, subject to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(c), </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">if, as and when declared by the Board of Directors, out of funds of the Corporation legally available therefor, on each Annual Dividend Payment Date for the applicable Payment Period or Payment Periods dividends on each outstanding share of Preferred Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Dividends</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) at a rate </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">per annum</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (calculated on the basis of an actual 365- or 366-day year, as applicable) equal to 8.00% of the Liquidation Preference per share of Preferred Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Dividend Rate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), payable in accordance with </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(a)(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> below. Subject to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, Annual Dividends shall accrue and accumulate on a daily basis from the Issuance Date of such share, whether or not declared and whether or not the Corporation has funds legally available for the payment of such dividends and shall be payable annually in arrears, if, as and when so authorized and declared by the Board of Directors, on each Annual Dividend Payment Date, commencing on the first Annual Dividend Payment Date following the Issuance Date of such share. Accrued Dividends, to the extent unpaid, shall in all cases be payable upon a Liquidation pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, upon a conversion of the Preferred Stock following a Fundamental Transaction pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8(g)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, or upon any conversion of the Preferred Stock pursuant to </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6(a)(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6(a)(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Annual Dividend payments shall be aggregated per Holder and shall be made to the nearest cent (with $0.005 being rounded upward).</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">5. Section 4(c) is hereby amended and restated to read as follows&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(c) If the Fundamental Transaction Date or Conversion Date or Call Date of any share of Preferred Stock is after an Annual Dividend Payment Record Date for a declared Annual Dividend on the Preferred Stock but occurs on or prior to the next Annual Dividend Payment Date, then the Holder of such share at the Close of Business on such Annual Dividend Payment Record Date will be entitled, notwithstanding the related Fundamental Transaction or conversion, as applicable, to receive, on or, at the Corporation&#8217;s election, before such Annual Dividend Payment Date, such declared Annual Dividend on such share. Except as provided in this Section 4(c), Annual Dividends on any share of Preferred Stock will cease to accumulate from and after the Fundamental Transaction Date or Conversion Date or Call Date, as applicable.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">6. The following is added as a new Section 7, and the subsequent sections of the Certificate of Designations are renumbered accordingly, with all cross references in the Certificate of Designations also being appropriately adjusted&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Section 7. Right of the Corporation to Call Outstanding Shares</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Call Option of Corporation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. The Corporation may, at any time and from time to time, call for conversion all or any portion of the outstanding shares of Preferred Stock and convert them into fully paid and non-assessable shares of Common Stock (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Call Option</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and such shares of Common Stock are sometimes referred to hereinafter as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Issued Common Call Shares</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as hereinafter provided. The Corporation may convert each outstanding share of Preferred Stock for which the Call Option is exercised into such number of fully paid and non-assessable shares of Common Stock equal to the quotient of (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) the sum of (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">1</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) the Liquidation Preference and (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) if the Corporation has not otherwise paid the Accrued Dividends to the Holder, the Accrued Dividends on such share as of the Call Date, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">divided by </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(B) the Conversion Price of such share in effect at the time of conversion.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. No fractional shares of Common Stock shall be issued upon the call of any shares of Preferred Stock. If more than one share of Preferred Stock subject to call is held by the same Holder, the number of full shares of Common Stock issuable upon call thereof shall be computed on the basis of the sum of (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) the aggregate Liquidation Preference and (</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">B</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">) the aggregate Accrued Dividends as of the Call Date on all shares of Preferred Stock so subject for which the Corporation has not otherwise paid such Accrued Dividends. If the call of any share or shares of Preferred Stock results in a fractional share of Common Stock issuable after application of the immediately preceding sentence, the Corporation shall pay a cash amount in lieu of issuing such fractional share in an amount equal to the value of such fractional interest multiplied by the 10-Day VWAP of a share of Common Stock determined on the Call Date.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Partial Call</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. In the case of any call of only part of the shares of Preferred Stock at the time outstanding, the shares to be called shall be selected either on a </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">pro rata</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> basis (as nearly as practicable without creating fractional shares) or by lot. Subject to the provisions hereof, the Board of Directors (or a duly authorized committee of the Board of Directors) shall have full power and authority to prescribe the terms and conditions on which shares of Preferred Stock shall be called from time to time. If the Corporation shall have issued certificates for Preferred Stock and fewer than all shares represented by any certificates are called, new certificates shall be issued representing the uncalled shares without charge to the Holders thereof.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Manner of Exercise</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-top:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(i) If the Corporation elects to exercise its Call Option, it shall mail a written notice (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Call Notice</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to each holder of record of the Preferred Stock by first class mail, postage prepaid, to the address indicated for each such holder in accordance with </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 11(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Any Call Notice mailed in this manner shall be conclusively presumed to have been duly given whether or not actually received, but failure duly to give such notice by mail, or any defect in such notice or in the mailing thereof, to any Holder of shares of Preferred Stock designated for call shall not affect the validity of the proceedings for the call of any other shares of Preferred Stock. Notwithstanding the foregoing, if the shares of Preferred Stock are issued in book-entry form through DTC or any other similar facility, notice of call may be given to the Holders of Preferred Stock at such time and in any manner permitted by such facility. The Call Notice shall specify (1) the Conversion Price, (2) the date fixed for the exchange of certificates (such date to be not less than ten (10) nor more than sixty (60) days after the date of such notice) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Call Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), (3) the number of shares of Preferred Stock to be called and, if less than all the shares of Preferred Stock held by such Holder are to be called, the number of shares of Preferred Stock to be called from such Holder or the method for determining such number, (4) instructions for the exchange of stock certificates, (5) the amount of Accrued Dividends as of the Call Date and that Accrued Dividends on such shares will cease to accrue on and after the Call Date, and (6) that the Issued Common Call Shares shall be issued in the same name or names in which the shares of Preferred Stock are held by such Holder.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(ii) The Corporation shall instruct the Transfer Agent to update the Register on the Call Date to reflect the shares of Common Stock held by such Holder as a result of the exercise of the Call Option and shall issue and deliver or cause to be issued and delivered to such Holder (A) evidence of such issuance reasonably satisfactory to such Holder and (B) cash for any fractional interest in respect of a share of Common Stock arising upon such conversion settled as provided in Section 7(b). If so required by the Corporation or the Transfer Agent, the Holder shall provide a written instrument or instruments of transfer in form reasonably satisfactory to the Corporation or the Transfer Agent, duly executed by the Holder or its legal representative.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(iii) Until the Call Date with respect to any share of Preferred Stock for which the Corporation has exercised its Call Option has occurred, such share of Preferred Stock will remain outstanding and will be entitled to all of the powers, designations, preferences and other rights provided herein, including that such share shall (A) accrue and accumulate Annual Dividends and participate in Participating Dividends pursuant to Section 4 and (B) entitle the Holder thereof to the voting rights provided in Section 9.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">NASDAQ Conversion Limits&#59; Solicitation of Stockholder Approval</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> of this Certificate of Designations, the Corporation may only exercise its Call Option with respect to a given Holder, and thereafter issue shares of Common Stock to such Holder upon conversion of the applicable called Preferred Stock to the extent (and only to the extent) that such conversion would not result in a given Holder (including its predecessors-in-interest) beneficially owning a number of shares of Common Stock in excess of the applicable Threshold Amount, unless such excess ownership has been approved by the Corporation&#8217;s stockholders (including at any special meeting of the Corporation&#8217;s stockholders) in accordance with the stockholder approval requirements of NASDAQ Marketplace Rule 5635 (or any equivalent rule or requirement of the applicable exchange or automated quotation system on which the Common Stock is then listed or quoted).</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">7. Former Section 7(a)(iv) (Adjustments to Conversion Price&#8212;Automatic Adjustment Upon Reset Dates) is struck.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">8. Former Section 7(d) (Adjustments to Conversion Price&#8212;Rounding of Calculations&#59; Minimum Adjustments) is hereby amended and restated to read as follows&#58;</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rounding of Calculations&#59; Minimum Adjustments</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">. All adjustments to the Conversion Price shall be calculated to the nearest one-tenth (1&#47;10th) of a cent. No adjustment in the Conversion Price shall be required if such adjustment would be less than $0.01&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, that any adjustments which by reason of this </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> are not required to be made shall be carried forward and taken into account in any subsequent adjustment&#59; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> that on any Conversion Date or Call Date adjustments to the Conversion Price will be made with respect to any such adjustment carried forward and which has not been taken into account before such date.</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page Follows</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Corporation has caused this Amendment to be signed by its duly authorized officer this 24</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> day of July, 2025.</font></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.467%"><tr><td style="width:1.0%"></td><td style="width:3.579%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:112%">TRISALUS LIFE SCIENCES, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">&#47;s&#47; Mary Szela</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Mary Szela</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">Chief Executive Officer and President</font></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex991closingofpsexchangeof.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i31ef0e6511d546b5943aea36e907fd0d_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 99.1</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">WESTMINSTER, CO &#8212; July 24, 2025</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; TriSalus Life Sciences&#174; Inc. (Nasdaq&#58; TLSI), a company focused on improving outcomes for patients with solid tumors, announced the completion of its previously disclosed exchange offer and consent solicitation for its Preferred Stock.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The offer expired one minute after 11&#58;59 p.m., Eastern Daylight Time, on July 23, 2025. Under the terms of the offer, TriSalus provided holders of its Preferred Stock the option to exchange each preferred share for 3.3 shares of its common stock. As previously disclosed, parties representing approximately 55% of the shares of Preferred Stock have agreed to tender their shares of Preferred Stock in the Offer and to consent to the Preferred Stock Amendment in the Consent Solicitation pursuant to tender and support agreements.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The company has been advised that the share of Preferred Stock tendered represented approximately 98.82% of the outstanding Preferred Stock. The Company expects to accept all validly tendered Preferred Stock for exchange and settlement on or before August 1, 2025.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The SEC declared the company&#8217;s Registration Statement on Form S-4 (Registration No. 333-288250), originally filed with the SEC on June 23, 2025, registering the shares issuable in the offer and pursuant to the amendment to Preferred Stock was declared effective by the SEC on July 22, 2025.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">TriSalus was assisted in the process by Sodali LLC (Information Agent)  and Continental Stock Transfer &#38; Trust Company (Exchange Agent). </font></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">About TriSalus Life Sciences</font></div><div style="text-indent:18pt"><font style="color:#232a31;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:112%">TriSalus Life Sciences&#174; is a growing, oncology focused medical technology business bringing disruptive drug delivery technology with the goal of improving therapeutic delivery for the treatment of both oncologic and non-oncologic conditions. Additionally, we are exploring the integration of our technology with our investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of liver and pancreatic indications. We have developed an innovative organ-specific platform that is designed to overcome two of the most significant challenges that prevent optimal delivery and performance of therapeutics in these difficult-to-treat diseases&#58; (i) high intratumoral pressure caused by tumor growth and collapsed vasculature restricting the delivery of oncology therapeutics and (ii) the immunosuppressive properties of liver and pancreatic tumor immune cells. By systematically addressing these barriers, we aim to improve response to therapies and to enable improved patient outcomes..</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#232a31;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In partnership with leading cancer centers across the country &#8211; and by leveraging deep immuno-oncology expertise and inventive technology development &#8211; TriSalus is committed to advancing innovation that improves outcomes for patients. Learn more at </font><font style="color:#1967d2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">trisaluslifesci.com</font><font style="color:#232a31;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and follow us on </font><font style="color:#1967d2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">X (formerly Twitter)</font><font style="color:#232a31;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#1967d2;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LinkedIn</font><font style="color:#232a31;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">No Offer or Solicitation</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This press release shall not constitute an offer to exchange or the solicitation of an offer to exchange or the solicitation of an offer to purchase any securities, nor shall there be any exchange or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. A registration statement on Form S-4 relating to the securities to be issued in the Offer has been filed with the SEC but has not yet become effective. Such securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. The Offer and Consent Solicitation are being made only through the Schedule TO and Prospectus&#47;Offer to Exchange, and the complete terms and conditions of the Offer and Consent Solicitation are set forth in the Schedule TO and Prospectus&#47;Offer to Exchange.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">None of the Company, any of its management or its board of directors, or the Information Agent, the Exchange Agent or the Solicitation Agent makes any recommendation as to whether or not holders of shares of Preferred Stock should tender shares of Preferred Stock for exchange in the Offer or consent to the Preferred Stock Amendment in the Consent Solicitation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain statements made in this press release are &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as &#8220;become,&#8221; &#8220;may,&#8221; &#8220;intend,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;believe&#8221; or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements may include, but are not limited to, statements regarding the consummation of the Offer and Consent Solicitation, the effects of the Offer on our capital structure and expected changes to the dilutive impact of the shares of Preferred Stock. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company&#8217;s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and may differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are subject to a number of risks and uncertainties, including, without limitation&#58; the Company&#8217;s ability to successfully complete the Offer and Consent Solicitation&#59; the number of holders of shares of Preferred Stock that approve the Preferred Stock Amendment in the Consent Solicitation&#59; the Company&#8217;s ability to attract and retain customers and expand customers&#8217; use of the Company&#8217;s products&#59; risks relating to market, financial, political and legal conditions&#59; risks relating to the uncertainty of the projected financial and operating information with respect to the Company&#59; risks related to future market adoption of the Company&#8217;s offerings&#59; risks related to the Company&#8217;s marketing and growth strategies&#59; risks related to the Company&#8217;s ability to acquire or invest in businesses, products or technologies that may complement or expand its products, enhance its technical capabilities or otherwise offer growth opportunities&#59; the effects of competition on the Company&#8217;s future business&#59; the risks discussed in the Company&#8217;s quarterly report on Form 10-Q for the period ended March 31, 2025 under the heading &#8220;Risk Factors&#8221;&#59; and the risks discussed in the Company&#8217;s Registration Statement on Form S-4 filed on June 23, 2025, under the heading &#8220;Risk Factors&#8221; and other documents of the Company filed, or to be filed, with the SEC. If any of these risks materialize or any of the Company&#8217;s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently does not know of or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company&#8217;s expectations, plans or forecasts of future events and views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Company&#8217;s assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by applicable law. These forward-looking statements should not be relied upon as representing the Company&#8217;s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For Media Inquiries&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Jeremy Feffer, Managing Director</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">LifeSci Advisors</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">917.749.1494</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">jfeffer&#64;lifesciadvisors.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">For Investor Inquiries&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Dan Giordano</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Vice President, Finance</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">815.405.6184</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Dan.giordano&#64;trisaluslifesci.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tlsi-20250724.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e4ff8340-6069-4af7-8725-d16f4b9c41e6,g:811176a3-0737-48fd-9061-9992c5c8ac23-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tlsi="http://trisaluslifesciences.com/20250724" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://trisaluslifesciences.com/20250724">
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlsi-20250724_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlsi-20250724_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlsi-20250724_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://trisaluslifesciences.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>tlsi-20250724_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e4ff8340-6069-4af7-8725-d16f4b9c41e6,g:811176a3-0737-48fd-9061-9992c5c8ac23-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://trisaluslifesciences.com/role/Cover" xlink:type="simple" xlink:href="tlsi-20250724.xsd#Cover"/>
  <link:definitionLink xlink:role="http://trisaluslifesciences.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_0af93798-c69f-4618-91bf-4f76cfad22ee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_DocumentInformationTable_0af93798-c69f-4618-91bf-4f76cfad22ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d39cb6c9-9c13-4e40-918b-327081036b44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_0af93798-c69f-4618-91bf-4f76cfad22ee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d39cb6c9-9c13-4e40-918b-327081036b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d39cb6c9-9c13-4e40-918b-327081036b44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d39cb6c9-9c13-4e40-918b-327081036b44" xlink:to="loc_us-gaap_ClassOfStockDomain_d39cb6c9-9c13-4e40-918b-327081036b44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d39cb6c9-9c13-4e40-918b-327081036b44" xlink:to="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cae38cbe-fe6a-446d-811f-64b9e207c9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:to="loc_us-gaap_CommonStockMember_cae38cbe-fe6a-446d-811f-64b9e207c9ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_b9fdca4c-9885-4baf-bc1a-f12c21f7d55c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:to="loc_us-gaap_WarrantMember_b9fdca4c-9885-4baf-bc1a-f12c21f7d55c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3b0bf867-ef85-4658-828e-d6633a689d5a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_DocumentType_3b0bf867-ef85-4658-828e-d6633a689d5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9c8ca127-ca5a-4ad0-8725-9af74e6eeabf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_DocumentPeriodEndDate_9c8ca127-ca5a-4ad0-8725-9af74e6eeabf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7db5d512-eefd-46cd-943a-5315ea7c7d6d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityRegistrantName_7db5d512-eefd-46cd-943a-5315ea7c7d6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0ded5a64-32ed-4246-afa2-0578b5e738b1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0ded5a64-32ed-4246-afa2-0578b5e738b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b92fc8d7-ac45-4cfe-a35a-db5c57ef3a62" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityFileNumber_b92fc8d7-ac45-4cfe-a35a-db5c57ef3a62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ea0b4f7c-a994-460b-937d-a47f1b5007ec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityTaxIdentificationNumber_ea0b4f7c-a994-460b-937d-a47f1b5007ec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a71fb704-5d5b-47fd-b9e7-b64e1fc8fd7d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressPostalZipCode_a71fb704-5d5b-47fd-b9e7-b64e1fc8fd7d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_707b99b1-d21c-4e67-9845-95f13635ee2f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressStateOrProvince_707b99b1-d21c-4e67-9845-95f13635ee2f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_743aa64b-98ea-49d6-afd5-312f453d07e3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressCityOrTown_743aa64b-98ea-49d6-afd5-312f453d07e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f09922e4-7c03-404e-a537-04de4edc3d17" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressAddressLine1_f09922e4-7c03-404e-a537-04de4edc3d17" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_42493675-f8bc-44c3-bc4b-911e1957cccc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_CityAreaCode_42493675-f8bc-44c3-bc4b-911e1957cccc" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6558056e-40d3-494f-8091-84e1bef369f9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_LocalPhoneNumber_6558056e-40d3-494f-8091-84e1bef369f9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_11a88642-22f8-443c-95c3-86c11a276e35" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_WrittenCommunications_11a88642-22f8-443c-95c3-86c11a276e35" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_49cc013a-9b28-450c-ad57-a91e8c832e26" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_SolicitingMaterial_49cc013a-9b28-450c-ad57-a91e8c832e26" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_154fa65f-0987-42c5-9bc0-f9414ead48d7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_PreCommencementTenderOffer_154fa65f-0987-42c5-9bc0-f9414ead48d7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_ae26706c-2dd0-4624-b901-a9749d704bc1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_ae26706c-2dd0-4624-b901-a9749d704bc1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8a3834c8-b9a8-4e57-957b-366d6978119b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_Security12bTitle_8a3834c8-b9a8-4e57-957b-366d6978119b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3687e02e-6a57-42f0-a4f5-82dd84eebbb3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_TradingSymbol_3687e02e-6a57-42f0-a4f5-82dd84eebbb3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f8d7025a-e61a-41f5-ad95-2cf97927ff59" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_SecurityExchangeName_f8d7025a-e61a-41f5-ad95-2cf97927ff59" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_56148a71-9e86-4a20-91b7-f726a55611b4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityEmergingGrowthCompany_56148a71-9e86-4a20-91b7-f726a55611b4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_53049953-6b67-46fc-8881-7134844b2136" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityExTransitionPeriod_53049953-6b67-46fc-8881-7134844b2136" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9caaf216-f6ee-4767-ac85-2012be4bc441" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityCentralIndexKey_9caaf216-f6ee-4767-ac85-2012be4bc441" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b498ab43-1e8c-47a2-b9b8-9ce9cf0977f7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_AmendmentFlag_b498ab43-1e8c-47a2-b9b8-9ce9cf0977f7" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3ca61bec-7625-42c8-a56d-48d3aa1a415b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_CurrentFiscalYearEndDate_3ca61bec-7625-42c8-a56d-48d3aa1a415b" xlink:type="arc" order="23"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>tlsi-20250724_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e4ff8340-6069-4af7-8725-d16f4b9c41e6,g:811176a3-0737-48fd-9061-9992c5c8ac23-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_fe18a9e3-4654-4a31-87b5-1c8fad45ae06_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_d928a40a-c31d-49cf-ae56-d9c5506baba9_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_51f6cd03-4faa-42de-9e29-9c35b6addf8d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8e69c2be-de1b-4339-b9ac-74d8a8294d7a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_d0da18ac-e5ad-40af-95f5-ec70b9cbf369_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_518174c3-960f-4c20-86dd-53c74289fb16_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_49653aa5-c410-4e5c-8967-53a0db0d2dee_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6111ea88-37c9-47cc-a443-5cd3af4ef2ea_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_24d4bbe7-5857-47f4-87da-9eabfe09b692_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_e7b9e695-7306-4095-b609-edc1512552ed_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e971beeb-e25b-46a5-84f0-e150d2a43995_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_338a2b92-aa8c-4b5c-a76e-40cb489a7100_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_25652894-d48b-4353-97d0-40c6d6775511_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9afce45a-b55e-47e6-ac22-1d304be63348_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d5230a4b-dd74-460f-a91a-920710fe16c8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_f35cc6af-2c8f-4217-b07b-fa05b319c7cf_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_744fdb30-1daf-4931-8347-70f89eadda84_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_cbf5e7db-fcc1-43c4-807c-477b05568cbe_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_aba991d0-f740-4862-be6a-68ca63a295e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4b133df9-55f9-473f-b849-329ac4dbdc55_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_0063a8d0-a188-489f-8dfa-08c86b5dd734_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_86d0c4a9-1b4e-4e43-b31b-6856077c3663_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cda4cc8a-d07f-4e46-89d5-1ea2847bf112_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_aef84a27-9eaf-43e9-b781-9c873bdbe5b2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_890f5155-7cac-4724-bcfd-0bf0c6d3d755_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_aad34fe5-99bb-40d3-9e8e-46b06304d573_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b786a266-38f8-4bb6-b589-6966b1bc52f0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_eded2460-7995-456d-9b7b-999355321e85_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_7ef6e6a4-9767-45b4-b7fe-d3be723c26b3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_34d49e18-9e6f-4da5-bf7e-a7a4d0dca2f7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>tlsi-20250724_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e4ff8340-6069-4af7-8725-d16f4b9c41e6,g:811176a3-0737-48fd-9061-9992c5c8ac23-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://trisaluslifesciences.com/role/Cover" xlink:type="simple" xlink:href="tlsi-20250724.xsd#Cover"/>
  <link:presentationLink xlink:role="http://trisaluslifesciences.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_43d323e7-79f3-4ead-b30c-7c21320e841e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_0af93798-c69f-4618-91bf-4f76cfad22ee" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_43d323e7-79f3-4ead-b30c-7c21320e841e" xlink:to="loc_dei_DocumentInformationTable_0af93798-c69f-4618-91bf-4f76cfad22ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d39cb6c9-9c13-4e40-918b-327081036b44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_0af93798-c69f-4618-91bf-4f76cfad22ee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d39cb6c9-9c13-4e40-918b-327081036b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d39cb6c9-9c13-4e40-918b-327081036b44" xlink:to="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_cae38cbe-fe6a-446d-811f-64b9e207c9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:to="loc_us-gaap_CommonStockMember_cae38cbe-fe6a-446d-811f-64b9e207c9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_b9fdca4c-9885-4baf-bc1a-f12c21f7d55c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_de64d425-c5c3-4b57-9835-eeb08004c68f" xlink:to="loc_us-gaap_WarrantMember_b9fdca4c-9885-4baf-bc1a-f12c21f7d55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_0af93798-c69f-4618-91bf-4f76cfad22ee" xlink:to="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_3b0bf867-ef85-4658-828e-d6633a689d5a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_DocumentType_3b0bf867-ef85-4658-828e-d6633a689d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9c8ca127-ca5a-4ad0-8725-9af74e6eeabf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_DocumentPeriodEndDate_9c8ca127-ca5a-4ad0-8725-9af74e6eeabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7db5d512-eefd-46cd-943a-5315ea7c7d6d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityRegistrantName_7db5d512-eefd-46cd-943a-5315ea7c7d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0ded5a64-32ed-4246-afa2-0578b5e738b1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0ded5a64-32ed-4246-afa2-0578b5e738b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b92fc8d7-ac45-4cfe-a35a-db5c57ef3a62" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityFileNumber_b92fc8d7-ac45-4cfe-a35a-db5c57ef3a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ea0b4f7c-a994-460b-937d-a47f1b5007ec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityTaxIdentificationNumber_ea0b4f7c-a994-460b-937d-a47f1b5007ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a71fb704-5d5b-47fd-b9e7-b64e1fc8fd7d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressPostalZipCode_a71fb704-5d5b-47fd-b9e7-b64e1fc8fd7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_707b99b1-d21c-4e67-9845-95f13635ee2f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressStateOrProvince_707b99b1-d21c-4e67-9845-95f13635ee2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_743aa64b-98ea-49d6-afd5-312f453d07e3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressCityOrTown_743aa64b-98ea-49d6-afd5-312f453d07e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f09922e4-7c03-404e-a537-04de4edc3d17" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityAddressAddressLine1_f09922e4-7c03-404e-a537-04de4edc3d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_42493675-f8bc-44c3-bc4b-911e1957cccc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_CityAreaCode_42493675-f8bc-44c3-bc4b-911e1957cccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6558056e-40d3-494f-8091-84e1bef369f9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_LocalPhoneNumber_6558056e-40d3-494f-8091-84e1bef369f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_11a88642-22f8-443c-95c3-86c11a276e35" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_WrittenCommunications_11a88642-22f8-443c-95c3-86c11a276e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_49cc013a-9b28-450c-ad57-a91e8c832e26" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_SolicitingMaterial_49cc013a-9b28-450c-ad57-a91e8c832e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_154fa65f-0987-42c5-9bc0-f9414ead48d7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_PreCommencementTenderOffer_154fa65f-0987-42c5-9bc0-f9414ead48d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_ae26706c-2dd0-4624-b901-a9749d704bc1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_ae26706c-2dd0-4624-b901-a9749d704bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8a3834c8-b9a8-4e57-957b-366d6978119b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_Security12bTitle_8a3834c8-b9a8-4e57-957b-366d6978119b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3687e02e-6a57-42f0-a4f5-82dd84eebbb3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_TradingSymbol_3687e02e-6a57-42f0-a4f5-82dd84eebbb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f8d7025a-e61a-41f5-ad95-2cf97927ff59" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_SecurityExchangeName_f8d7025a-e61a-41f5-ad95-2cf97927ff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_56148a71-9e86-4a20-91b7-f726a55611b4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityEmergingGrowthCompany_56148a71-9e86-4a20-91b7-f726a55611b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_53049953-6b67-46fc-8881-7134844b2136" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityExTransitionPeriod_53049953-6b67-46fc-8881-7134844b2136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9caaf216-f6ee-4767-ac85-2012be4bc441" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_EntityCentralIndexKey_9caaf216-f6ee-4767-ac85-2012be4bc441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b498ab43-1e8c-47a2-b9b8-9ce9cf0977f7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_AmendmentFlag_b498ab43-1e8c-47a2-b9b8-9ce9cf0977f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3ca61bec-7625-42c8-a56d-48d3aa1a415b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a0ca8f50-52a9-4582-b4e1-1000baf2449c" xlink:to="loc_dei_CurrentFiscalYearEndDate_3ca61bec-7625-42c8-a56d-48d3aa1a415b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 24, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 24,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TRISALUS LIFE SCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39813<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-3009869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80031<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Westminster<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6272 W 91st Ave<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(888)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">321-5212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001826667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLSI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each whole warrant exercisable for one share of registrant's common stock at an exercise price of $11.50 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLSIW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tlsi-20250724.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trisaluslifesciences.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tlsi-20250724.htm">tlsi-20250724.htm</File>
    <File>tlsi-20250724.xsd</File>
    <File>tlsi-20250724_def.xml</File>
    <File>tlsi-20250724_lab.xml</File>
    <File>tlsi-20250724_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tlsi-20250724.htm": {
   "nsprefix": "tlsi",
   "nsuri": "http://trisaluslifesciences.com/20250724",
   "dts": {
    "inline": {
     "local": [
      "tlsi-20250724.htm"
     ]
    },
    "schema": {
     "local": [
      "tlsi-20250724.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "tlsi-20250724_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tlsi-20250724_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tlsi-20250724_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 27
   },
   "report": {
    "R1": {
     "role": "http://trisaluslifesciences.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tlsi-20250724.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tlsi-20250724.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant",
        "label": "Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://trisaluslifesciences.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001826667-25-000103-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001826667-25-000103-xbrl.zip
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M#.!8"E\'0&$(O4$;I$C972_+-#Y]>/0RM6.C[T[1=P_ !$6I3FD(N.U@  3
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MY"I%P<K-AA*D($/%!$:CONN(2(J#?3MDI3"58"!9(^G'"88I8#'B(&?B :'
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MQ9DUIF_TN4("H[H#H0Y0[6V)D.NQC%*XB'\%2QZ2ERQY? ")X#DP0!3IG0K
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M,E1E'DW''CV?*<HZ1(!<OS.:WSRY]C/.'G&VO'G=RDAS)6[QXG.,NC<[3O?
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MN#-X+VJ%\RF[L#W3PT@D%9NKR(/O'/G)!P:"8;I],7#-N:*S'%W24%>:GJC
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MRJVL7A;RH)C>"O5T.8'=F"]^2EV$89@=F]1%DO&!57B:S]?U2&&<\=G% 2<
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MB.) SM,><.:"(9[^XMBU_,4QL4.F<T_\Q5(_<*;PSR :>N?_!5!+ P04
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M=3);KDTFKMA3F=T;%8XV*Q3I(JG8?OMM4E)\D.(D C-;(U_8$@FB?_37;#1
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MQBKF;0<_:7YO4(_AWDWN(I_[JQ":V+:G==O9\K_%U9!>K"+)*<P13#<.@92
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M+ $48B8O#)D&%&D$E" AIX+K!%OGA?N CBS#IQ/3+>S@:X4>U/"6@AQTUW"
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M_#^*%9N,2W"-%)$F( H1 9@("-*0"%.^$QXBA%/!K7OO^D".7< WL$&#&U3
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MV,5/+Y[<G.A_]?^?X<63_P)02P$"% ,4    " ##B_A:C@:;1;T6  "HH0
M'@              @ $     97@S,6-E<G1I9FEC871E;V9A;65N9&UE;G0N
M:'1M4$L! A0#%     @ PXOX6OY!-G!F#P  S#L  !X              ( !
M^18  &5X.3DQ8VQO<VEN9V]F<'-E>&-H86YG96]F+FAT;5!+ 0(4 Q0    (
M ,.+^%H8^_6U\A0  *:1   1              "  9LF  !T;'-I+3(P,C4P
M-S(T+FAT;5!+ 0(4 Q0    ( ,.+^%KZE,R^C@(  )$(   1
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7;%!+!08     !P ' -\!   [70     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>tlsi-20250724_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tlsi-20250724.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826667</identifier>
        </entity>
        <period>
            <startDate>2025-07-24</startDate>
            <endDate>2025-07-24</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826667</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-24</startDate>
            <endDate>2025-07-24</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826667</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-24</startDate>
            <endDate>2025-07-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001826667</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-26">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-27">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-07-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">TRISALUS LIFE SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39813</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">85-3009869</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6272 W 91st Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Westminster</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">80031</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">(888)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">321-5212</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-17">Common stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-18">TLSI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-20">Warrants, each whole warrant exercisable for one share of registrant's common stock at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-21">TLSIW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-24">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
